4//SEC Filing
Shaaltiel Yoseph 4
Accession 0001209191-10-022637
CIK 0001006281other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 5:27 PM ET
Size
5.2 KB
Accession
0001209191-10-022637
Insider Transaction Report
Form 4
Shaaltiel Yoseph
DirectorExecutive VP, R&D
Transactions
- Sale
Common Stock
2010-04-14$7.00/sh−1,309$9,163→ 882,445 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001385118
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 5:27 PM ET
- Size
- 5.2 KB